Rush University Medical Center is among the backers of Transcarent’s series C round, which pushed the company’s overall financing to $298m.

Transcarent, a US-based operator of a personalised healthcare platform for employers, secured $200m in a series C round on Tuesday from a consortium featuring Rush University Medical Center, the teaching hospital of Rush University. Kinnevik and Human Capital co-led the round, with participation from health systems Northwell Health and Intermountain Healthcare, pharmaceutical firm Merck &…

The rest of this content is only accessible to Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.